Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Bordetella bronchiseptica aroA mutant as a live vaccine vehicle for heterologous porcine circovirus type 2 major capsid protein expression.

Veterinary microbiology - 18 Sept 2009

Kim Taejung, Toan Nguyen Tat, Seo Jayoung, Jung Bockgie, Lee Jaeil, Lee Bongjoo

Abstract excerpt

Porcine circovirus type 2 (PCV2) infections cause important respiratory diseases in the pig industry and are associated with many bacterial, mycoplasmal, and viral complications. In this study, a heterologous PCV2 major capsid protein (MCP) was expressed in the Bordetella bronchiseptica aroA mutant strain (BBS-MCP) and used as a live vaccine vehicle. Mice and pigs were immunized with live BBS-MCP via the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Administration, Intranasal
Share to Bordetella bronchiseptica

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Capsid Proteins

Share to Circovirus

Share to Gene Expression Regulation, Bacterial

Share to Viral Proteins

Share to Viral Vaccines

Source

Identifiers

PMID: 19428194
DOI: 10.1016/j.vetmic.2009.04.014

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Bordetella bronchiseptica aroA mutant as a live vaccine vehicle for heterologous porcine circovirus type 2 major capsid protein expression.PMID 19428194Read ↗

Surface Display of porcine circovirus type 2 antigen protein cap on the spores of bacillus subtilis 168: An effective mucosal vaccine candidateSemantic proximity Read ↗

Displaying epitope B and epitope 7 of porcine reproductive and respiratory syndrome virus on virus like particles of porcine circovirus type 2 provides partial protection to pigsSemantic proximity Read ↗

Immune response in piglets orally immunized with recombinant Bacillus subtilis expressing the capsid protein of porcine circovirus type 2.Semantic proximity Read ↗

Heterologous expression of porcine reproductive and respiratory syndrome virus glycoprotein 5 in Bordetella bronchisepticaaroA mutant.Semantic proximity Read ↗

Killed whole-genome reduced-bacteria surface-expressed coronavirus fusion peptide vaccines protect against disease in a porcine modelSemantic proximity Read ↗

Oral Bacillus subtilis spores-based vaccine for mass vaccination against porcine reproductive and respiratory syndromeSemantic proximity Read ↗

Construction and immunogenicity of recombinant pseudotype baculovirus expressing the capsid protein of porcine circovirus type 2 in miceSemantic proximity Read ↗

Engineering a bivalent nanoparticle vaccine with PCV2 capsid protein and PRRSV epitopesSemantic proximity Read ↗

Immunogenicity and Immunoprotection of PCV2 Virus-like Particles Incorporating Dominant T and B Cell Antigenic Epitopes Paired with CD154 Molecules in Piglets and MiceSemantic proximity Read ↗

A genetically engineered chimeric vaccine against porcine circovirus type 2 (PCV2) is genetically stable in vitro and in vivo.Semantic proximity Read ↗

Use of a genetically defined double mutant strain of Bordetella bronchiseptica lacking adenylate cyclase and type III secretion as a live vaccine.Semantic proximity Read ↗

Oral Bacillus subtilis Spores-based Vaccine for Mass Vaccination against Porcine Reproductive and Respiratory SyndromeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.